Top 50 Medical Startup Investors in United Kingdom (November 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Scottish Enterprise
VC Fund
|
35 | United Kingdom, United States, Switzerland | Grant, Seed, Venture - Series Unknown | Biotechnology, Software, Health Care | $119k–$6.3M |
|
UK Innovation & Science Seed Fund
VC Fund
|
30 | United Kingdom, United States | Seed, Venture - Series Unknown | Biotechnology, Health Care, Medical | $512k–$6.7M |
|
Parkwalk Advisors
VC Fund
|
30 | United Kingdom, United States, Philippines | Seed, Series A, Series B | Biotechnology, Health Care, Software | $991k–$44M |
|
SFC Capital
VC Fund
|
29 | United Kingdom, United States, Ireland | Seed, Pre-Seed, Venture - Series Unknown | Software, Artificial Intelligence, Information Technology | $125k–$2.5M |
|
SOSV
VC Fund
|
28 | United States, China, Canada | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | $25k–$5M |
|
Oxford Science Enterprises
VC Fund
|
22 | United Kingdom, United States, Finland | Seed, Series A, Series B | Health Care, Biotechnology, Medical | $1.3M–$168M |
|
Deepbridge Capital
VC Fund
|
21 | United Kingdom, Spain, Australia | Seed, Venture - Series Unknown, Series A | Health Care, Biotechnology, Medical | $142k–$15M |
|
Future Planet Capital
VC Fund
|
19 | United Kingdom, United States, Singapore | Seed, Series A | Biotechnology, Health Care, Software | $482k–$20M |
|
Northstar Ventures
VC Fund
|
18 | United Kingdom, United States, Indonesia | Seed, Venture - Series Unknown, Series A | Software, Information Technology, Health Care | $45k–$10M |
|
Scottish Investment Bank
VC Fund
|
17 | United Kingdom, United States, France | Venture - Series Unknown, Seed, Series A | Software, Biotechnology, Information Technology | $179k–$7.5M |
|
Archangels
VC Fund
|
17 | United Kingdom, United States | Venture - Series Unknown, Seed | Software, Health Care, Biotechnology | $795k–$6.6M |
|
Development Bank of Wales
VC Fund
|
16 | United Kingdom, Australia, United States | Seed, Debt Financing, Venture - Series Unknown | Software, Manufacturing, Health Care | $19k–$5.9M |
|
Oxford Technology Management
VC Fund
|
15 | United Kingdom, United States | Seed, Series A | Biotechnology, Health Care, Software | $41k–$8.5M |
|
AlbionVC
VC Fund
|
15 | United Kingdom, United States, France | Series A, Seed, Venture - Series Unknown | Software, Artificial Intelligence, Health Care | $253k–$19M |
|
Cambridge Innovation Capital
VC Fund
|
15 | United Kingdom, United States, Ireland | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $831k–$73M |
|
Empirical Ventures
VC Fund
|
14 | United Kingdom | Seed, Pre-Seed | Biotechnology, Medical, Health Care | $924k–$5.8M |
|
Calculus Capital
VC Fund
|
14 | United Kingdom, United States, Ireland | Venture - Series Unknown, Series A | Biotechnology, Software, Medical | $1.7M–$10M |
|
Mercia Fund Managers
VC Fund
|
14 | United Kingdom, United States, Hungary | Seed, Venture - Series Unknown, Series A | Software, Health Care, Biotechnology | $233k–$14M |
|
GM&C Life Sciences Fund
VC Fund
|
13 | United Kingdom, Italy, Germany | Seed, Venture - Series Unknown, Series A | Health Care, Biotechnology, Medical | $94k–$5.8M |
|
Jonathan Milner
Angel
|
13 | United Kingdom, United States, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $505k–$56M |
|
Innovate UK
VC Fund
|
13 | United Kingdom, United States, Ireland | Grant, Pre-Seed, Seed | Health Care, Biotechnology, Software | $58k–$3.5M |
|
Business Growth Fund
VC Fund
|
13 | United Kingdom, Ireland, United States | Venture - Series Unknown, Private Equity, Series A | Software, Manufacturing, Information Technology | $3.4M–$22M |
|
IP Group
VC Fund
|
12 | United Kingdom, United States, Australia | Seed, Series A, Series B | Biotechnology, Health Care, Software | $44k–$68M |
|
Catapult Ventures
VC Fund
|
12 | United Kingdom, United States, Israel | Seed, Venture - Series Unknown | Health Care, Biotechnology, Medical | $150k–$5.6M |
|
Mercia Asset Management
VC Fund
|
11 | United Kingdom, United States | Venture - Series Unknown, Series A, Seed | Software, Information Technology, Health Care | $576k–$13M |
|
Oxford Capital
VC Fund
|
11 | United Kingdom, United States, France | Seed, Venture - Series Unknown | Software, Health Care, Biotechnology | $1.2M–$8M |
|
Newable Private Investing
VC Fund
|
11 | United Kingdom, United States | Seed, Series A | Software, Health Care, Biotechnology | $196k–$5.6M |
|
Praetura Ventures
VC Fund
|
11 | United Kingdom, Australia, Germany | Venture - Series Unknown, Seed, Series A | Software, Information Technology, Artificial Intelligence | $364k–$7M |
|
SyndicateRoom
VC Fund
|
11 | United Kingdom, United States, India | Seed, Equity Crowdfunding, Pre-Seed | Health Care, Software, Medical | $390k–$2.7M |
|
M Ventures
VC Fund
|
10 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.4M–$100M |
|
The FSE Group
VC Fund
|
9 | United Kingdom, United States, Canada | Debt Financing, Seed, Venture - Series Unknown | Software, Manufacturing, Information Technology | $106k–$5.4M |
|
Foresight Group
VC Fund
|
9 | United Kingdom, United States, Ireland | Venture - Series Unknown, Private Equity, Seed | Software, Information Technology, Manufacturing | $648k–$8.3M |
|
Speedinvest
VC Fund
|
9 | United Kingdom, Germany, Austria | Seed, Series A, Pre-Seed | Software, FinTech, Artificial Intelligence | $411k–$32M |
|
Nesta Ventures
VC Fund
|
9 | United Kingdom, United States | Venture - Series Unknown, Seed | Biotechnology, Medical Device, Medical | $569k–$22M |
|
Maven Capital Partners
VC Fund
|
9 | United Kingdom, United States, Germany | Venture - Series Unknown, Seed, Private Equity | Software, Information Technology, Manufacturing | $648k–$13M |
|
SIS Ventures
VC Fund
|
8 | United Kingdom | Seed, Series A, Venture - Series Unknown | Health Care, Biotechnology, Medical | $1.1M–$33M |
|
Providence Investment Company Limited
VC Fund
|
8 | United Kingdom | Series A, Series B | Biotechnology, Biopharma, Medical | $2.2M–$30M |
|
Eos
VC Fund
|
8 | United Kingdom, Ireland | Seed, Series A | Biotechnology, Health Care, Medical | $1.5M–$47M |
|
Forbion Capital Partners
VC Fund
|
8 | United States, United Kingdom, The Netherlands | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $16M–$180M |
|
Wellcome Trust
VC Fund
|
8 | United States, United Kingdom, France | Grant, Series C, Series B | Biotechnology, Health Care, Medical | $1.6M–$127M |
|
Syncona Partners LLP
VC Fund
|
8 | United Kingdom, United States, Switzerland | Series A, Series B, Seed | Biotechnology, Medical, Health Care | $1.9M–$156M |
|
Triple Point Ventures
VC Fund
|
7 | United Kingdom, United States, Ireland | Seed, Series A, Pre-Seed | Financial Services, Software, Health Care | $891k–$16M |
|
Gabriel Investments
VC Fund
|
7 | United Kingdom | Seed, Pre-Seed, Series A | Medical, Biotechnology, Manufacturing | $302k–$4.1M |
|
Crista Galli Ventures
VC Fund
|
7 | United Kingdom, United States, Sweden | Seed, Pre-Seed, Series A | Health Care, Medical, Wellness | $623k–$14M |
|
QUBIS
VC Fund
|
7 | United Kingdom, United States | Seed, Venture - Series Unknown | Health Care, Biotechnology, Medical | $604k–$5.7M |
|
Google Ventures
VC Fund
|
7 | United States, United Kingdom, Israel | Series A, Series B, Seed | Software, Health Care, Biotechnology | $1.1M–$125M |
|
Hoxton Ventures
VC Fund
|
7 | United Kingdom, United States, Canada | Seed, Series A, Series B | Artificial Intelligence, Software, Health Care | $1.9M–$35M |
|
Salica
VC Fund
|
7 | United Kingdom, United States, Germany | Seed, Secondary Market, Series A | Software, Information Technology, Health Care | $645k–$346M |
|
Eli Lilly
VC Fund
|
7 | United States, United Kingdom, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $7M–$150M |
|
Octopus Ventures
VC Fund
|
7 | United Kingdom, United States, Germany | Series A, Seed, Series B | Software, Artificial Intelligence, Health Care | $1.9M–$43M |
| Access all 1566 investors in United Kingdom Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Grant, Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 410
- Round size: Seed $406k–$4.3M; Grant $119k–$5.3M; Venture - Series Unknown $566k–$6.3M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- GLORIAH — Explore plant-based intimate hydration oils, water-based personal gels, fragrance roll-ons and product sets designed for simple everyday routines.
- SolarSub — SolarSub is an environmental firm that offers floating solar cooling system.
- INEOS O&P USA — INEOS O&P USA specializes in producing raw materials that are essential in the manufacture of a wide variety of goods under various sectors.
UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom, United States
Investor stats
- Total investments: 151
- Round size: Seed $512k–$5.9M; Venture - Series Unknown $1M–$6.7M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
- StandardX — StandardX is a deep-tech company building the isotope refinery powered by a scalable, compact particle accelerator platform.
- SILVIA BIO — SilVia Bio develops technologies to analyze and optimize mammalian cell factories used in biomanufacturing. The company focuses on identifying critical parameters that limit bioproduction yield and product quality in cell systems such as CHO and HEK cells. Its platform provides cell profiling services that generate interpretable data on manufacturing-relevant bottlenecks. Based on these insights, SilVia Bio designs and supplies precision media additives formulated to address specific rate-limiting cellular processes. The offerings are intended for biopharmaceutical and biomanufacturing teams seeking to improve titre, cell performance, and consistency in production processes. SilVia Bio also collaborates with industrial partners to apply its platform within real manufacturing environments.
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009, anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth. Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Philippines
Investor stats
- Total investments: 356
- Round size: Seed $991k–$4.9M; Series A $1.6M–$14M; Series B $1.7M–$44M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Adsilico — Explore how virtual populations and in silico trials help medical device teams understand variation and build stronger evidence.
- Illumion — Illumion develops high-throughput optical tools to accelerate battery material development
- MoA Technology — We harness the principles of natural selection to accelerate discovery for better, safer herbicides so farmers can continue to feed the world.
Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 804
- Round size: Seed $125k–$1.9M; Pre-Seed $170k–$846k; Venture - Series Unknown $201k–$2.5M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — raised $1.9M in 2019
Portfolio highlights
- Obsero — Obsero is an AI search intelligence platform and consultancy designed for marketing and communications teams. The platform tracks, measures, and optimizes how brands surface, get cited, and are recommended across Large Language Models (LLMs) and AI search assistants.
- Surghive — Surghive provides a platform-agnostic virtual reality (VR) and AI-enabled training intelligence platform designed to solve the robotic surgical training bottleneck in healthcare.
- Overtone — Decibels Audio Ltd. is a London-based technology company that designs and manufactures Overtone, a specialized audio device engineered for personalized sound enhancement. Crafted from bio-acetate and titanium, the device utilizes a finely tuned sound engine developed alongside audiological experts to improve speech clarity and support everyday hearing experiences.
SOSV offers pre-seed capital and follow-on financial support to startups focusing on deep technology and scientific innovation. Founders utilize purpose-built laboratory facilities and engineering spaces to accelerate product development and testing. The firm facilitates connections between entrepreneurs and a network of investors through structured matchmaking events and technology summits.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, China, Canada
Investor stats
- Total investments: 3821
- Round size: Seed $125k–$5M; Pre-Seed $25k–$1.5M; Convertible Note $50k–$3.6M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $306M in 2023
Portfolio highlights
- Halla — Halla Intelligence is a digital solution that leverages over 100 billion shopper and product data points to recommend and promote what grocery items.
- Verdex Technologies — Verdex Technologies is an advanced materials platform technology that uses nanofibers to disrupt industries. Verdex doesn't just compete, it innovates and disrupts.
- Samphire Neuroscience — Samphire Neuroscience builds clinically validated neurotechnology to support women across their lives. Our wearable devices, Nettle™ and Lutea™, are built on the same underlying brain-stimulation technology, targeting neural pathways involved in pain, mood, stress, and sleep regulation. - Lutea™ is available globally as a wellness device. Itstimulates the same regions of the brain to support stress regulation, sleep, and recovery - key drivers of readiness and long-term performance - allowing athletes and teams to move beyond wellbeing education alone to practical, evidence-based intervention. - Nettle™ is a CE-marked (EU and UK regulated), drug- and hormone-free device that has been clinically shown to improve pain, mood, functionality, and the ability to train during the menstrual cycle, with measurable benefits after one month of use - supporting athletes to maintain training intensity and movement quality during their period. - The Samphire App is the platform controlling all Samphire hardware products with the use of CycleSync™ AI technology: the only one of its kind to support personalized neurotechnology use for women.
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking on challenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Finland
Investor stats
- Total investments: 210
- Round size: Seed $1.3M–$12M; Series A $6.3M–$45M; Series B $9.1M–$168M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $299M in 2022
Portfolio highlights
- Salience Labs — Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.
- OMass Therapeutics — OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise their potential and become successful leading-edge businesses.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, Spain, Australia
Investor stats
- Total investments: 91
- Round size: Seed $142k–$2.4M; Series A $2M–$15M; Venture - Series Unknown $259k–$2.8M
- Lead/follow: 69% lead, 31% follow
- Last fund: Likely still investing — raised $1.4M in 2022
Portfolio highlights
- upLYFT — upLYFT creates next-generation wearable technology that continuously analyses biomechanics and movement biomarkers, giving athletes, clinicians and physiotherapists precise insight into performance, recovery and injury risk.
- GeneralPractice.AI — GeneralPractice.AI - Infusing Artificial Intelligence into the Fabric of General Practice
- Spotlight Pathology — Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.
Brilliant Ideas. Brilliant People. Brilliant Minds.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Singapore
Investor stats
- Total investments: 313
- Round size: Seed $482k–$5.1M; Series A $1.4M–$20M
- Lead/follow: 4% lead, 96% follow
- Last fund: Likely still investing — raised $23M in 2022
Portfolio highlights
- Unloq AI — Unloq is a decision intelligence platform that helps businesses understand why a choice makes sense, what actions to take, and whether they deliver results.
- Nourished — At Nourished we create innovative. personalised nutrition stacks that are truly unique to you. Vegan, waste-free and always made to order.
- K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, United States, Indonesia
Investor stats
- Total investments: 373
- Round size: Seed $45k–$1.3M; Series A $295k–$10M; Venture - Series Unknown $363k–$3.6M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $20M in 2024
Portfolio highlights
- OneClickComply — OneClickComply automates ISO 27001, SOC 2, Cyber Essentials and 240+ standards: evidence from 13,000+ tools, one-click fixes and an in-house audit team.
- Land Digital — Land Digital is a tech, web design, web creation, content marketing, digital marketing, SEO, and mobile application agency.
- Magnitude Biosciences — Magnitude Biosciences is a biotechnology firm combine experience in ageing research, the nematode C. elegans and automation.
Speak with our team, who can help you find sources of finance, engage with funders and secure investment to grow your business.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 314
- Round size: Seed $331k–$3.2M; Series A $1.7M–$7.5M; Venture - Series Unknown $179k–$4.1M
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Corvidae — Corvidae is a software company that provides data analysts, digital marketing, e commerce, and paid media solutions.
- IOTech — Discover IOTech Systems. Deploy, manage, and scale AI-driven, data-rich industrial systems at the edge with our open edge data platform.
- RoslinCT — We are the prefered global partner for cell and gene therapy solutions. With our wealth of expertise and infrastructure, we can support you at every step of your advanced therapy journey.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Venture - Series Unknown, Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 88
- Round size: Seed $1.3M–$6.6M; Venture - Series Unknown $795k–$6.3M
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- CSignum — Revolutionising underwater communications with electromagnetic technology for seamless data integration between surface & submerged devices.
- Corvidae — Corvidae is a software company that provides data analysts, digital marketing, e commerce, and paid media solutions.
- iGii — Integrated Graphene enable better products with a revolutionary design for manufacture process producing the world's highest quality pure 3D Graphene Foam, Gii.
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more...Investment focus
- Industry: Software, Manufacturing, Health Care
- Stage:Seed, Debt Financing, Venture - Series Unknown
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 301
- Round size: Seed $327k–$2.5M; Debt Financing $19k–$3.7M; Venture - Series Unknown $383k–$5.9M
- Lead/follow: 61% lead, 39% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- Design and Supply — Design and Supply provides products and services primarily for the construction industry, offering Jansen-certified products and British SBD solutions. The company manufactures and supplies items, including steel doors. Additionally, Design and Supply caters to design enthusiasts by offering artwork, fine furniture, antiques, and decor.
- MeOmics Technology — MeOmics Technology is a biotech company with a focus on improving the diagnosis and treatment of mental health illnesses. The company operates in the manufacturing industry and has a team of 9 employees. The team includes experts in Neuronal Cell Biology and Neuropsychopharmacology. The company's mission is to leverage technology to enhancethe understanding and treatment of mental health conditions.
- Outlook Expeditions — Outlook Expeditions provide overseas educational expeditions, adventure travel and service-learning projects for schools.
Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 113
- Round size: Seed $41k–$2.2M; Series A $786k–$8.5M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — last raise in 2012
Portfolio highlights
- OrganOx — OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford.
- HydRegen — HydRegen is a biotechnology company that provides sustainable solutions for chemical manufacturing. HydRegen was founded in 2020 and was headquartered in Oxford, United Kingdom.
- Metacarpal — Metacarpal design upper-limb prosthetics without compromise. We aim to make the most robust, functional hand prosthesis that people love wearing because it works so effectively and looks so beautiful. Be proud to show your artificial side!
AlbionVC backs Europe’s visionary founders solving the world’s hardest problems. We bring capital, know-how, and a shared ambition to win. With £1 billion in venture funds and convictionled investing across frontier technologies, our track record spans 100+ exits and early support for global champions such as Booking.com, Quantexa, Oviva, Elliptic and tem. From the first concept to global scale, we back founders bold enough to own the future.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 180
- Round size: Seed $2.4M–$12M; Series A $3.9M–$19M; Venture - Series Unknown $253k–$7.8M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Oshen — Oshen is a technology enterprise that creates miniature autonomous sailboats designed for persistent, wide-area ocean tracking.
- Outerlimit — Outerlimit is an AI security company focused on securing and governing agentic AI systems. Its platform provides visibility into AI agent activity, identity and access controls, risk assessment, and runtime security. The company helps organizations establish security and governance controls for AI agents operating across enterprise environments and manage their access to applications, data, and systems.
- Gravitee — Open Source API Management Platform - Gravitee
As a team, we have a passion for science and its potential to drive change. Through our expertise and our position in one of the country's most powerful science and technology ecosystems, we're able to identify and support the most promising entrepreneurs in knowledge intensive businesses and help them achieve their vision.With our financial backing and expert guidance, we're excited to enable the pioneers in life sciences and deep tech to create world-leading companies whose unique ideas bring financial success and global impact.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 123
- Round size: Seed $831k–$31M; Series A $2.5M–$73M; Series B $8.2M–$68M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely actively investing — fresh fund, raised $332M in 2025
Portfolio highlights
- Microbiotica — Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and invivo models.
- Salience Labs — Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.
- TRIMTECH Therapeutics — Transformative treatments for CNS and inflammatory disorders by selectively destroying disease-causing protein aggregates
Empirical Ventures is a specialist VC and venture builder backing the world's boldest early-stage deep-tech and life-science companies, built by scientists.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 41
- Round size: Seed $924k–$5.8M; Pre-Seed $1.1M–$1.6M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $10M in 2024
Portfolio highlights
- MintNeuro — MintNeuro is pioneering the use of semiconductor technology in next-generation neural implants.
- BoobyBiome — BoobyBiome harnesses breast milk microbiome science to develop products to improve infant health
- Optera — Optera are a leading specialist structural repair company located in the West Midlands, which provides the ideal base for giving national coverage. Optera offer specialist structural solutions to problems widely encountered within the domestic property sector and are engaged daily to provide solutions to the Insurance market place.
At Calculus Capital they are specialists in creating and managing tax efficient private equity funds for the individual. Funds that are ideal for today's market - offering generous tax benefits, and significant growth potential within a sensible risk profile. They look to make £2-5 million investments in established companies with proven management teams and a successful product or service. Their entrepreneurial flair, combined with their experience and sound commercial judgement has resulted in a diversified investment portfolio and an impressive track record. In June 2013 Calculus Capital was top ranked in the prestigious Martin Churchill Tax Efficient Review for the 6th year in a row. The Government has recently shown its support for EIS funds, by maintaining the five generous tax benefits and widening the scope of EIS investments. These changes benefit Calculus Capital's rigorous and proven strategy. As a result they are experiencing their strongest pipeline of prospective investments yet.
Show more...Investment focus
- Industry: Biotechnology, Software, Medical
- Stage:Venture - Series Unknown, Series A
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 82
- Round size: Series A $2.5M–$10M; Venture - Series Unknown $1.7M–$8.3M
- Lead/follow: 66% lead, 34% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Edify Systems — Edify connects ordering, stock, production planning and reporting across your sites, taking on the everyday work so your team can focus on customers.
- Grateful — Grateful provides cashless tipping and trunk management software that integrates QR/NFC, EPOS systems, and compliance reporting.
- Resurrect Bio — Resurrect Bio discovers crop disease-resistance traits, using AI and high-throughput in-planta screening to deliver them to seed companies up to 10x faster.
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, United States, Hungary
Investor stats
- Total investments: 158
- Round size: Seed $233k–$2M; Series A $1.3M–$14M; Venture - Series Unknown $394k–$5.9M
- Lead/follow: 64% lead, 36% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- Ben — Ben is the all-in-one platform for any company to personalise benefits and reward.Our secret? Marrying a modern software (SaaS) platform with per-employee Mastercards and financial infrastructure. That’s how Ben instantly adds employee choice to your existing benefits, unlocks access to hundreds of additional options through Ben Card, all whilesaving you time and money.
- Distil.ai — Distil.ai is a software platform that helps businesses to understand their customers’ behavior and identify buying signals.
- MRC Engineering — MRC Engineering Providing a different option to the UK Rail Industry for Telecoms Design. Nationally renowned design specialists who provide extraordinary ...
The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, Italy, Germany
Investor stats
- Total investments: 36
- Round size: Seed $94k–$1.9M; Series A $1.9M–$4.2M; Venture - Series Unknown $4.3M–$5.8M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
- Infex Therapeutics — Infex Therapeutics acquire, develop and license drugs to treat pandemic infections.
- Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon Discovery Group plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 63
- Round size: Seed $505k–$25M; Series A $4.5M–$50M; Series B $1.6M–$56M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 470+ centers worldwide.
- Nuclera — Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Innovate UK is part of the UK Research and Innovation .
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Grant, Pre-Seed, Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 1279
- Round size: Seed $291k–$3.5M; Grant $62k–$2M; Pre-Seed $58k–$1.3M
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- Plasma2X — Plasma2X is a clean-tech company that develops technology to produce green fertilizers, fuels, and critical chemicals.
- Emerald — Comprehensive in-clinic biomarker testing, GP-reviewed results with past health data integration and personalised action plan. Designed to help you understand your risks earlier and act with medical support.
- MoniRail — MoniRail develops non-intrusive rail monitoring systems that combine onboard sensors with cloud-based data analytics. The company provides an in-service measurement solution using lightweight inertial sensors mounted on ordinary trains to monitor track geometry, ride comfort, and vehicle dynamics. Its software platform processes motion and positional data into actionable insights on track and vehicle condition to support predictive maintenance and reduce service disruption. MoniRail also works on quantum-based navigation systems for rail, addressing positioning challenges where satellite signals are unavailable. Its solutions are used by rail infrastructure owners, operators, and rolling stock fleets seeking to optimise maintenance planning and asset performance.
BGF is the most active equity investor in the UK and Ireland, providing long-term, minority investment to growing companies.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Venture - Series Unknown, Private Equity, Series A
- Geography: United Kingdom, Ireland, United States
Investor stats
- Total investments: 629
- Round size: Series A $4.1M–$21M; Private Equity $6M–$22M; Venture - Series Unknown $3.4M–$16M
- Lead/follow: 86% lead, 14% follow
- Last fund: Likely still investing — raised $97M in 2022
Portfolio highlights
- Camino — Camino Leisure Holdings is a Spanish bar and restaurant that serves authentic food and wines.
- OCL Vision — Expert eye care from trusted UK specialists. From laser vision correction to cataract surgery, discover life-changing treatments.
- Granite Digital — GRANITE is a digital agency with expertise in technology & strategy providing clients with Digital Transformation services including Web Design, Development, SEO, PPC, email marketing and Social Media as well as online software & app development.
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and create value out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Australia
Investor stats
- Total investments: 261
- Round size: Seed $44k–$5.3M; Series A $2.4M–$30M; Series B $7.9M–$68M
- Lead/follow: 20% lead, 80% follow
- Last fund: Likely actively investing — fresh fund, raised $50M in 2026
Portfolio highlights
- Microbiotica — Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and invivo models.
- Matter Machine — Matter Machine is an AI-driven materials discovery company that creates technologies that use materials chemistry, machine learning, and automated experimentation to speed up the discovery and optimization of next-generation materials.
- Mach42 — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
The team behind Catapult Ventures are among the most experienced venture capital investors in the UK. Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of pounds in revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 105
- Round size: Seed $150k–$5.6M; Venture - Series Unknown $370k–$5M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Path Robotics — We create manufacturing robots that autonomously scan, position, and weld your parts without the need for skilled welders or robot programmers.
- Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
- Anello Photonics — Anello Photonics is a technology company developing a silicon photonic optical gyroscope to navigate, position, and motion track autonomous applications in challenging GPS-jammed and spoofed environments. The company's technology portfolio spans over 28 issued patents, and over 44 pending patents, and includes an AI-based sensor fusion engine.It serves the robotics, defense, construction, agriculture, and autonomous vehicles industries.
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 112
- Round size: Seed $576k–$3.2M; Series A $2.2M–$13M; Venture - Series Unknown $659k–$12M
- Lead/follow: 63% lead, 37% follow
- Last fund: May invest from a new fund soon — raised $38M in 2018
Portfolio highlights
- StratoBayes — Automated stratigraphic correlation with quantified uncertainty, built on Bayesian statistical inference.
- Camena Bioscience — Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications. It has engineered new nucleic acid synthesis technology which improves the quality and speed of synthesis. Its multi-enzymatic technology takes one approach to DNA, RNA, and XNA synthesis, offering increased accuracy over existingPhosphoramidite synthesis technology.Camena Bioscience was founded in 2016 and is headquartered in Cambridge.
- Warwick Acoustics Ltd — Warwick Acoustics is a UK-based technology company specialising in the development of HighRes Audio solutions for the automotive and headphone markets based on its patented High Precision Electrostatic Laminate technology (HPELs). Their ultra thin, lightweight HPELs deliver audiophile performance across a bandwidth several octaves greater thantraditional moving coil speakers in a form factor that is less than one quarter the weight, and one tenth of the thickness. In addition, HPELs offer designers unparalleled flexibility to shaped and form a speaker to individual design requirements.
Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 167
- Round size: Seed $1.7M–$3.9M; Venture - Series Unknown $1.2M–$8M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $66M in 2015
Portfolio highlights
- Flyttr — Flyttr is the leader in developing and deploying biosecurity countermeasures against critical pest threats that spread disease, threaten food security.
- Scan.com — Use scan.com to find the best medical imaging centers near you Find an MRI scan, CT scan, X-ray Scan, or other diagnostic imaging scan with scan.com.
- Noggin HQ — The next generation of credit referencing is coming. Look busy.
Newable exists to power business growth. Our strategy of Buy, Grow, Realise focuses on the regulated B2B market.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 110
- Round size: Seed $196k–$3.2M; Series A $1.5M–$5.6M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
- Weldfast — Weldfast is a manufacturer and supplier of welding consumables, abrasives, chemicals, premium gas equipment, and safety products.
- EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
Praetura Ventures has been supporting entrepreneurs with more than money since 2011. Click to find out more about how we can help businesses and investors.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: United Kingdom, Australia, Germany
Investor stats
- Total investments: 167
- Round size: Seed $655k–$4.5M; Series A $3.1M–$7M; Venture - Series Unknown $364k–$6.6M
- Lead/follow: 79% lead, 21% follow
- Last fund: Likely still investing — raised $123M in 2022
Portfolio highlights
- Tended — Tended creates advanced solutions to change how people work and improve employee safety across high-risk industries. Through a combination of wearable technology and behavioural science, Tended's main focus is to drive positive behavioural change, which has proven benefits on both an individual and organisational level.Tended'ssolutions are currently improving safety across industry-leading companies in sectors including construction, manufacturing, utilities and logistics.
- Holdson — Holdson is an electrochemical polishing machine tool supplier aiming to address the issue of inconsistent surface finishes on additive manufactured components.The technology is producing intellectual property through patents, providing a competitive advantage in the advanced machinery industry.
- PEAK:AIO — PEAK:AIO delivers software-defined storage for AI, enabling fast, scalable data infrastructure and optimized GPU utilization.
SyndicateRoom is fintech company made up of data-scientists, investment professionals, software developers and marketers with one mission: to be an early investor in every British startup success story. To do this – and make fund investors money – we don’t try to spot the next Big Thing. Instead, we apply a data-driven model to portfolio construction; a repeatable process designed to maximise returns and minimise risk for fund investors. As such, we build startup portfolios that don’t attempt to predict the future; they work to stack the odds in investors’ favour. Our fund, Access EIS, aims to build investors a diversified portfolio of 50+ companies by co‑investing exclusively with some of the UK’s best-performing angel investors.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Equity Crowdfunding, Pre-Seed
- Geography: United Kingdom, United States, India
Investor stats
- Total investments: 154
- Round size: Seed $390k–$2.7M; Pre-Seed $425k–$1.9M; Equity Crowdfunding $390k–$2.5M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Nuuri — Nuuri is the UK nursery finder helping parents compare settings, discover local events, understand costs and choose with confidence.
- aflo — aflo automates inhaler techniques to improve the management of respiratory conditions.
- Atlian Insurance — Atlian Insurance provides sensor-enabled construction insurance that uses real-time site data to adjust coverage, prevent risks, and automate claims.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 190
- Round size: Seed $2.4M–$24M; Series A $5.8M–$56M; Series B $13M–$100M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Mueon — semiconductor-based systems for AI and hyperscale computing
- Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
- iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The FSE Group provides growth finance and support for ambitious UK businesses, helping SMEs start, scale and succeed through tailored funding solutions.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Debt Financing, Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 287
- Round size: Seed $294k–$2.6M; Debt Financing $106k–$633k; Venture - Series Unknown $485k–$5.4M
- Lead/follow: 74% lead, 26% follow
- Last fund: Likely still investing — raised $88M in 2023
Portfolio highlights
- Spotta — Spotta's smart pest systems help pest control monitor and identify pests. Solutions for hospitality, care homes, agriculture, farming and forestry.
- Amino —
- Alchera Technologies — Alchera's AI-powered, cloud-based software platform provides real-time data on the movement of vehicles and pedestrians around cities and major infrastructure
Foresight Group is a listed infrastructure and private equity investment manager which has been managing funds on behalf of institutions and retail clients for more than 35 years. Foresight has over £7.2 billion of assets under management across a number of funds on behalf of some of the world’s largest institutional investors, family offices, private and high net-worth individuals and retail investors. Foresight's investment strategies are underpinned by a strong environmental, social & governance (“ESG”) focus, which increasingly meets the demands of today’s investors and ensures we are consistently working towards creating a sustainable legacy for future generations.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Venture - Series Unknown, Private Equity, Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 239
- Round size: Seed $648k–$7.3M; Private Equity $2.1M–$8.3M; Venture - Series Unknown $979k–$6.5M
- Lead/follow: 63% lead, 37% follow
- Last fund: Likely actively investing — fresh fund, raised $120M in 2025
Portfolio highlights
- Vertal — Vertal is a food waste recycling company
- nisien.ai — Nisien.ai uses industry-leading AI for the detection, defence and resolution of online harm, for better online safety and digital wellbeing.
- VS Group — Communications and IT solutions are constantly evolving and changing. We can find a solution that meets your needs and budget.
Speedinvest is a globally active European venture capital firm built on a simple belief: many move more. From six offices across EMEA, our sector-focused investment teams back relentless founders from pre–Seed to Growth with long-term conviction, providing day-one access to our global network of corporate customers, experts, industry leaders, and top-tier follow-on investors to scale smarter and faster. Building lasting companies like Bitpanda (Austria), Moove (Nigeria), Gigs (U.S.), Tide (UK), ARX Robotics (Germany), Wayflyer (Ireland), GoStudent (Austria), Seqera Labs (Spain), and Cylib (Germany) — together. Big ideas may start with one. But scaling and winning take The Power of More.
Show more...Investment focus
- Industry: Software, FinTech, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 684
- Round size: Seed $798k–$7.9M; Pre-Seed $411k–$3.8M; Series A $4.1M–$32M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $372M in 2022
Portfolio highlights
- Findery — Find and leave notes anywhere in the world, discover local knowledge, hidden secrets, and exciting stories. Share your travel knowledge, geoblog, or local news!
- GAMINSIDE — GAMINSIDE revolutionizes your relationship with your customers. As European full service provider, we deliver the complete package with solutions, services and software for gamified loyalty that is tailor-made and unique to your products, brands and customers. Integrate the best ideas from gamification and customer loyalty in your business areato exceed your commercial targets with GAMINSIDE.
- Polaron — Polaron connects process, structure, and performance using AI and image data to accelerate how materials are characterised, designed, and manufactured.
We bring bold ideas to life to change the world for good.
Show more...Investment focus
- Industry: Biotechnology, Medical Device, Medical
- Stage:Venture - Series Unknown, Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 77
- Round size: Seed $569k–$2.2M; Venture - Series Unknown $5M–$22M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $41M in 2014
Portfolio highlights
- Citymart — Citymart powers cities to deliver services that work. Following best practices developed with leading cities around the world, Citymart connects cities and revolutionizes the way cities frame needs, complete procurements, and improve service delivery. Over 100 cities in 35 countries have adopted Citymart tools and methods to-date.
- Featurespace — The Featurespace Platform offers cutting-edge, real-time machine learning solutions to prevent fraud and financial crime. Learn more today.
- Radio Physics Solutions — PASAR123 merupakan landasan utama bandar slot nomor 1 di indonesia memiliki fasilitas slot deposit pulsa tanpa potongan penarikan sangat mudah dan cepat.
Maven is one of the UK's leading private equity and investment firms. We provide essential capital and expertise to help businesses unlock their potential.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Venture - Series Unknown, Seed, Private Equity
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 239
- Round size: Seed $783k–$5M; Private Equity $1.1M–$13M; Venture - Series Unknown $648k–$8.3M
- Lead/follow: 74% lead, 26% follow
- Last fund: May invest from a new fund soon — raised $132M in 2019
Portfolio highlights
- KubeNet — We are KubeNet - a multi-award winning technology solutions provider based in Glasgow. Whether it's Managed IT, IT Support, Cloud, Connectivity, Voice or Cyber Security, we're by your side as your trusted technology partner.
- Tixserve — Secure, Trackable, Interactive Digital Tickets for Live Events
- ReadyGo Diagnostics — ReadyGo Diagnostics has invented a novel “Diagnostic Pen”. Low cost, intuitive to use from the raw sample, the ReadyGo Pen will be a game-changer in the newly emerging consumer diagnostics market, offering a yes/no answer in minutes, based on molecular analysis.
SIS Ventures has been created with the overall aim of supporting and growing high impact organisations through access to mission-aligned investment. SIS Ventures has a goal of becoming the go to investor and partner for social entrepreneurs. The fund will offer conventional financial returns alongside social and/or environmental returns byinvesting either equity or debt into purpose driven companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United Kingdom
Investor stats
- Total investments: 33
- Round size: Seed $1.1M–$4.9M; Series A $2.8M–$21M; Venture - Series Unknown $1.6M–$33M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — raised $1.3M in 2018
Portfolio highlights
- Dxcover — Dxcover are a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
- MiAlgae — MiAlgae is a new-age microalgal production company that aims to revolutionize the £340 billion global livestock feed industry by producing microalgal products – through the remediation of wastewater – as nutrient supplements for fishmeal in livestock feeds. Their microalgal products are high in omegas and proteins, both of which are required forthe production of many livestock feeds, especially in the aquaculture sector.Their production methodology uses circular economy to reduce the operating costs involved in the production of microalgae and as such allows them to compete with other supplements currently on the market.
- Solasta Bio — Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.
Providence Investment Company
Show more...Investment focus
- Industry: Biotechnology, Biopharma, Medical
- Stage:Series A, Series B
- Geography: United Kingdom
Investor stats
- Total investments: 15
- Round size: Series B $2.2M–$30M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- evonetix — evonetix is a new spin-out company that is currently incubating in the centre of the world-renowned Cambridge cluster of high-tech and life science organisations. We are seeking to develop and commercialise a new approach to the synthesis of DNA to facilitate the fast-emerging and exciting field of synthetic biology. By employing novel techniqueswe are able to advance DNA synthesis to levels never before seen. Our engineering team has decades of experience developing high integrity automated systems. Our high calibre team brings together expertise from across the scientific and engineering disciplines.
- pixlbio (formerly DefiniGEN) — Generate metabolic disease phenotypes in primary-like human cells using the best-in-class human iPSC differentiation platform. Find out more here!
- Cambridge Photon Technology — Cambridge Photon Technology is a developer of organic photovoltaic devices used to enhance next-generation solar technology. Its devices engage in the deployment of off-grid solar power and use advanced nanotechnology to split each incoming blue and green photon into two infra-red photons that enable clients to deploy solar power throughlightweight devices whenever needed.
Eos invests in, & commercialises, science & technology, from local seed-stage to global scale, with a focus on improving lives.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, Ireland
Investor stats
- Total investments: 45
- Round size: Seed $1.5M–$11M; Series A $1.6M–$47M
- Lead/follow: 58% lead, 42% follow
Portfolio highlights
- TaiSan — A polymer-electrolyte sodium battery for the e-bike and scooter fleet.
- Nami Surgical — Despite advances in robotic surgery, integrated ultrasonic energy remains unavailable in wristed robotic surgical systems
- Scarlet Therapeutics — Scarlet Therapeutics is developing the novel red blood cell-based therapeutics (tRBCs) generation platform.
Impacting the future of medicine.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 229
- Round size: Series A $20M–$180M; Series B $16M–$155M; Series C $22M–$123M
- Lead/follow: 51% lead, 49% follow
- Last fund: Likely actively investing — fresh fund, raised $606M in 2026
Portfolio highlights
- OMass Therapeutics — OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
- Lisata Therapeutics — Lisata is a clinical-stage pharmaceutical company dedicated to improving lives through the discovery, development, and commercialization of innovative medicines.
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Grant, Series C, Series B
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 126
- Round size: Grant $1.6M–$10M; Series B $18M–$68M; Series C $10M–$127M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $331M in 2018
Portfolio highlights
- Lario Therapeutics — Lario Therapeutics are developing first-in-class disease modifying treatments for severe neurological disorders. Precision Neuroscience Today.
- Wysa — Use Wysa to vent or just talk through negative thoughts and emotions. Let it help you cope with pandemic anxiety and lockdowns. It is anonymous, safe and free.
- Ineffable Intelligence — Ineffable Intelligence is an AI research company whose mission is to make first contact with superintelligence.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 78
- Round size: Seed $1.9M–$17M; Series A $13M–$87M; Series B $29M–$156M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- OMass Therapeutics — OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
- Re-Aim Therapeutics — Re‑Aim Therapeutics is a UK‑based biotech start‑up developing functional cures for T cell–mediated autoimmune diseases by selectively depleting pathogenic T‑cell subsets. Its lead asset, REA‑001, is a monoclonal antibody designed to potently and precisely eliminate disease‑causing type‑17 T cells, aiming to reset the immune system and achievedurable, treatment‑free remission in multiple autoimmune conditions.
Investment management that activates capital across a range of industries, asset classes and sectors, connecting legacies with growth and businesses with better futures.
Show more...Investment focus
- Industry: Financial Services, Software, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 104
- Round size: Seed $1.6M–$7.6M; Pre-Seed $891k–$4M; Series A $4.9M–$16M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $40M in 2018
Portfolio highlights
- Perch Group — Perch Group is a credit and asset management company that offers debt purchase and debt collection services.
- Ayan — At Ayan, we offer Halal, ethical and transparent car financing solutions across the UKOur financing model is built on fairness and clarity. No interest, no hidden costs, and no confusing terms- just Shariah-compliant finance tailored to real needs. We’re committed to supporting individuals and businesses with solutions that align with theirprinciples.As we continue to grow across the UK, our mission remains simple: to provide accessible, ethical financial options that help our customers secure the vehicles they need- while staying true to their values.Credit is subject to status and affordability checks.Ayan Capital 1 Ltd is authorised and regulated by the Financial Conduct Authority (FRN: 1021505)
- The Electric Car Scheme — Salary sacrifice lets employees pay for an electric car from their gross salary before tax. It's basically the Cycle to Work scheme but for electric cars.
Gabriel Investments opens the door to new businesses, quickly and simply.
Show more...Investment focus
- Industry: Medical, Biotechnology, Manufacturing
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 22
- Round size: Seed $302k–$2M; Pre-Seed $407k–$564k; Series A $803k–$4.1M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Mirna — Soon to be launched, our AI-powered MI:RNA platform is designed to detect a range of diseases prior to the development of clinical signs. This groundbreaking
- Seluna — Seluna is developing medical software to help doctors advance clinical diagnostics for paediatric sleep disorders.
- Regeno Energy — Regeno Resources accelerating the goal of clean energy with inexpensive, self-installing wind turbines.
Physician-led venture capital investing in TechBio, DeepTech Healthcare, and Digital Health.
Show more...Investment focus
- Industry: Health Care, Medical, Wellness
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Sweden
Investor stats
- Total investments: 37
- Round size: Seed $960k–$9.2M; Pre-Seed $623k–$2.5M; Series A $5.7M–$14M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Jude — Science-backed food supplement that makes you feel empowered, not embarrassed.
- Vitrue Health — At Vitrue Health, our mission is to reduce or eliminate the impact that musculoskeletal health issues have on over 40% of the population using cutting edge technology. We believe that the foundation of successful outcomes in musculoskeletal health, at every stage of the pathway, is accurate assessment. Whether it's a desk worker with early stages of neck pain or a patient having a total knee replacement, Vitrue's technology can help.
- Collective Minds — Collective Minds develops and delivers a cloud-based collaboration platform for healthcare and research with access to data, human and digital expertise.
Working with academic entrepreneurs, QUBIS Ltd has grown a portfolio of shareholdings in viable companies over 27 years that have succeeded on an international level.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom, United States
Investor stats
- Total investments: 39
- Round size: Seed $604k–$2.6M; Venture - Series Unknown $1.3M–$5.7M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- aflo — aflo automates inhaler techniques to improve the management of respiratory conditions.
- StimOxyGen — StimOxyGen specializes in developing innovative, pH-responsive nanoparticles designed to generate oxygen in hypoxic tumors. This technology aims to enhance the effectiveness of cancer treatments such as radiotherapy and chemotherapy by addressing tumor hypoxia, a significant clinical challenge. F
- AMPLY Discovery — AMPLY Discovery is to develop new biological molecules for anti-infective health and nutrition applications in animal and human health.
GV supports innovative founders moving the world forward.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 1582
- Round size: Seed $1.1M–$14M; Series A $6M–$100M; Series B $15M–$125M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $100M in 2014
Portfolio highlights
- Tennr — Tennr is a custom AI assistant that accelerates research, answers complex questions, and generates custom reports.
- ngmoco — ngmoco ("Next Generation MObile COmpany") is creating and producing games for the iPhone. CEO Neil Young is a former executive from Electronic Arts, where he oversaw the development of several hit titles. Another EA vet and partner at Kleiner Perkins, Bing Gordon, sits on the board. Kleiner is an investor through its iFund.
- SolveAI —
Hoxton Ventures focuses on startups that either disrupt existing industries or invent entirely new market categories. Hoxton typically invests between $500,000 and $5 million into pre-seed, seed, and Series A stage companies, and follows its capital through the life of the company. The firm is based in London and invests all across Europe.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 141
- Round size: Seed $1.9M–$12M; Series A $5M–$28M; Series B $6M–$35M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $60M in 2026
Portfolio highlights
- Preply — Looking for a tutor? Preply is the best platform for private online lessons with a flexible payment system and affordable prices. Book your first lesson.
- Veridion — Veridion is a living digital replica of the business world. Decision-grade data for enterprise scale systems
- Fabrica AI — Fabrica AI offers a revolutionary platform for faster robot development, using custom hardware designs and learned optimal control to increase efficiency while minimizing complexity and cost. With a vision for a future where robot development takes days, not years.
Founded as an investment firm focusing on the most promising startups, we have evolved into a unique set of private market funds investing globally in equity and debt across complementary sectors and stages. We fuse traditional values with a contemporary approach and balance exacting processes with the agility to capture commercial opportunity and compelling investment returns. Our continuous search for new opportunities has led us to create a balanced collection of complementary funds and relationships.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Secondary Market, Series A
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 249
- Round size: Seed $645k–$4.3M; Series A $3.9M–$19M; Secondary Market $60M–$346M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely actively investing — fresh fund, raised $12M in 2026
Portfolio highlights
- Moneybox — Moneybox is the simple way to save, invest, buy your first home, and combine your old pensions - all with one award-winning app. Download now.
- CameraMatics — Digitize fleet management to optimize performance. Onboard sensors, smart cameras, & apps to mitigate risk, manage safety & achieve sustainability goals.
- Modern Milkman — The Modern Milkman is the fresh way to protect the planet! Join our milkround's fight against waste with sustainably packaged, plastic free grocery deliveries.
Lilly is a medicine company that puts health above all. Learn about our medicines, view condition support, find care, and much more.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 153
- Round size: Series A $7M–$94M; Series B $11M–$150M; Series C $11M–$107M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Thatch — Thatch is an all-in-one platform that makes it easy to offer the most personalized healthcare experience to your employees using an ICHRA.
- Circle Pharma — Circle Pharma is an early-stage biotechnology company applying proprietary computational design algorithms and innovative chemistry to develop cell-permeable macrocycle peptide therapeutics against important clinical targets. It does this through an iterative, rational design process that deploys large virtual libraries of conformationally diversemacrocycle scaffolds selected for inherent permeability. The company was founded by Matt Jacobson and Scott Lokey in 2012 and is headed by David J. Earp.
- BigHat Biosciences — We use machine learning and synthetic biology to design and engineer antibody therapeutics.
We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 455
- Round size: Seed $1.9M–$12M; Series A $3.4M–$22M; Series B $8M–$43M
- Lead/follow: 56% lead, 44% follow
- Last fund: May invest from a new fund soon — raised $108M in 2019
Portfolio highlights
- Braid — Braid is a telecom and connectivity infrastructure provider that abstracts global mobile networks into programmable APIs and SDKs. The company enables digital brands to embed cellular connectivity directly into their apps, products, or user journeys without dealing with legacy telecom procurement, Capex, or lengthy carrier negotiations.
- Grasp — Grasp is the world's first AI analyst for finance professionals. Our AI analyst automates company and market research for investment banks, private equity firms, and management consulting firms across the world.
- Monkey Bizness — Monkey Bizness is the largest provider of indoor family entertainment centres in the UK. Each centre includes a children's soft play area and is designed to provide a safe, clean and fun environment in which parents and children can feel comfortable. Monkey Bizness' centres provide a setting that encourages children to express themselvesthrough creativity and play as well as providing fresh and nutritious food to keep kids happy and healthy.Monkey Bizness currently has centres in eight locations: Lewes, Gosport, Poole, Sheffield, Stevenage, Hull Edinburgh and Glasgow.
Medical Investor funding in United Kingdom at a glance
Stats across 1.9k deals from 1.6k investors.
Access all 1566 investors in United Kingdom Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Investors in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 1566 investors investing in United Kingdom Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!